*Some Market data delayed by 15 mins.

CytomX Therapeutics, Inc.

Symbol: CTMX (NASDAQ)
1.90 ▲ (0.53%) 0.010

Company Description:
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Key Stats
  • Today's Open: $1.91
  • Today's High: $1.945
  • Today's Low: $1.855
  • Today's Volume: 1.66M
  • Yesterday Close: $1.89
  • Yesterday High: $1.97
  • Yesterday Low: $1.85
  • Yesterday Volume: 3.54M
  • Last Min Volume: 559
  • Last Min High: $1.9
  • Last Min Low: $1.9
  • Last Min VWAP: $1.9
Company Profile
  • Name: CytomX Therapeutics, Inc.
  • Website: https://www.cytomx.com
  • Listed Date: 2015-10-08
  • Location: SOUTH SAN FRANCISCO, CA
  • Market Status: Active
  • CIK Number: 0001501989
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $149.61M
  • Round Lot: 100
  • Outstanding Shares: 77.92M
  • Asset Type: CS
RECENT FILINGS FOR CTMX
Filing DateFiling TypeFormat
2024-05-174View
2024-05-174View
2024-05-174View
2024-05-174View
2024-05-174View
2024-05-174View
2024-05-174View
2024-05-178-KView
2024-05-13SC 13GView
2024-05-088-KView
2024-05-088-KView
2024-05-0810-QView
2024-05-01DEFA14AView
2024-04-04DEFA14AView
2024-04-04DEF 14AView
2024-03-284View
2024-03-25PRE 14AView
2024-03-224View
2024-03-223View
2024-03-228-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.